Existing investors WuXi PharmaTech and Mayo Clinic took part in a series B round that will help Unity Biotechnology move preclinical candidates into human trials.

Blue Cross Blue Shield of Arizona's investment subsidiary has backed four healthcare startups since its launch a year ago.

Pfizer, Takeda and BB Biotech invested a combined $88m in the offering, conducted less than five months after Myovant spun out of Roivant Sciences.

The pharmaceutical firm's European affiliate has joined limited partners including Cleveland Clinic, Maccabi Healthcare Services and Medison Pharma.

GV has participated in a series A round for Genomics Medicine Ireland, joining investors such as the government-owned Ireland Strategic Investment Fund.

Existing backer Lundbeckfond Ventures returned to take part in a debt and equity round that took the bone repair technology producer's total financing past $70m.

Novo, Novartis and Amgen all recorded exits as blood disorder therapeutics developer Ra floated in the middle of its range.

Massachusetts Institute of Technology has unveiled an incubator that will provide funding, space and expertise to boost commercialisation activities on and off-campus.

University of California, Riverside is set to open an incubator today dubbed Epic as it gears up to raise a VC fund to provide seed capital.